Richard Malamut - Nov 13, 2024 Form 4 Insider Report for Chromocell Therapeutics Corp (CHRO)

Role
Director
Signature
/s/ Francis Knuettel II, under Power of Attorney dated August 1, 2023, from Richard Malamut
Stock symbol
CHRO
Transactions as of
Nov 13, 2024
Transactions value $
$0
Form type
4
Date filed
11/15/2024, 04:20 PM
Previous filing
Sep 16, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CHRO Restricted Stock Units Award +24.5K +26.79% 116K Nov 13, 2024 Common Stock 24.5K $0.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On November 13, 2024, the Reporting Person was granted restricted stock units to purchase 24,533 shares of common stock at an exercise price of $0.64 per share, which shall vest on a quarterly basis over a period of six (6) quarters.